ED Pathway for Evaluation/Treatment of Children with Sickle Cell Disease
Sickle Cell Disease and Fever
This pathway should be used for patients > 2 months of age with SS, SC, or Sβ-thalassemia type sickle cell disease who have a temperature ≥ 38.5°C or history of temperature ≥ 38.5°C within 48 hours of presentation.
Legal Disclaimer: These clinical pathways are based upon the opinions of staff members of The Children's Hospital of Philadelphia. Treatment should be individualized and based upon the clinical conditions of each patient.